Menu

Ghostly Experiment

A robot replicates the neurological phenomenon that causes people to feel like another person is nearby.

Nov 10, 2014
Molly Sharlach

FLICKR, TUNCAY

The hallucination of a ghostly presence is common among people with psychiatric disorders such as schizophrenia and sometimes occurs in healthy people under extreme conditions. To investigate the cause of this “feeling of presence” (FoP), researchers at the École Polytechnique Fédérale de Lausanne in Switzerland and their colleagues observed study participants’ reactions to a specially designed robot that mimicked their movements. The findings, reported last week (November 6) in Current Biology, suggest that FoP results from a mismatch between perceptions of the self and of external signals. 

As part of the study, the team scanned the brains of 12 patients who had reported FoP and discovered lesions in the frontoparietal cortex, which integrates sensory and motor signals and is involved in self-awareness. This led to the idea that FoP is prompted by conflict between external and internal inputs. To test this hypothesis, the researchers created a “master-slave” robot to recreate the phenomenon in healthy people. Blindfolded participants used their index fingers to move a robotic arm in front of them, while a robot behind them made the same movements on their backs. When the movements were simultaneous, people felt as if they were touching their own backs, but delaying the robot’s motions by a half-second produced the illusion of another person behind them.

“Our brain possesses several representations of our body in space,” study coauthor Giulio Rognini told BBC News. “Under normal conditions, it is able to assemble a unified self-perception of the self from these representations,” he explained. “But when the system malfunctions because of disease—or, in this case, a robot—this can create a second representation of one’s own body, which is no longer perceived as ‘me’ but as someone else, a ‘presence’.”

In the future, Rognini and his team hope to create a robot that can help schizophrenic patients to differentiate their own actions from those of others.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.